<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: IPN.PA News</title><copyright>Copyright (c) 2013 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=ipn.pa</link><description>Latest Financial News for IPSEN</description><language>en-US</language><lastBuildDate>Thu, 25 Apr 2013 05:12:08 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: IPN.PA News</title><link>http://finance.yahoo.com/q/h?s=ipn.pa</link><width>144</width><height>45</height></image><item><title>BRIEF-Ipsen says confirms its 2013 guidance</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12cs1qr2e/*http://www.reuters.com/article/2013/04/25/ipsen-brief-idUSWEB003OV20130425?feedType=RSS&amp;feedName=rbssHealthcareNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/61002116</guid><pubDate>Thu, 25 Apr 2013 05:12:08 GMT</pubDate></item><item><title>Ipsen’s First Quarter 2013 Sales</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ipsen-first-quarter-2013-sales-050200780.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/1714277966</guid><pubDate>Thu, 25 Apr 2013 05:02:00 GMT</pubDate></item><item><title>Ipsen expects Increlex® supply interruption due to supplier manufacturing issues</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ipsen-expects-increlex-supply-interruption-050100825.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/3129993851</guid><pubDate>Thu, 25 Apr 2013 05:01:00 GMT</pubDate></item><item><title>Active Biotech and Ipsen Update the Analysis Plan for the 10TASQ10 Trial Evaluating Tasquinimod in the Treatment of Prostate Cancer</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/active-biotech-ipsen-analysis-plan-050000675.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/139293436</guid><pubDate>Thu, 25 Apr 2013 05:00:00 GMT</pubDate></item><item><title>Combined Shareholders’ Meeting of Ipsen on 31 May 2013: Proposals of Renewal of the Terms of Office of Two Directors and Appointment of a New Director</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/combined-shareholders-meeting-ipsen-31-163000960.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/298525015</guid><pubDate>Wed, 24 Apr 2013 16:30:00 GMT</pubDate></item><item><title>Cosmetic Procedures Need Tighter Restrictions: U.K. Panel</title><link>http://us.rd.yahoo.com/finance/external/bloomberg/rss/SIG=137monr70/*http://www.bloomberg.com/news/2013-04-23/cosmetic-procedures-need-tighter-restrictions-u-k-panel.html?cmpid=yhoo</link><description></description><guid isPermaLink="false">yahoo_finance/3601025898</guid><pubDate>Tue, 23 Apr 2013 23:01:00 GMT</pubDate></item><item><title>Doctors Should Welcome a Nudge to Wash Their Hands</title><link>http://us.rd.yahoo.com/finance/external/bloomberg/rss/SIG=132h8outb/*http://www.bloomberg.com/news/2013-04-15/doctors-should-welcome-a-nudge-to-wash-their-hands.html?cmpid=yhoo</link><description></description><guid isPermaLink="false">yahoo_finance/2634225394</guid><pubDate>Mon, 15 Apr 2013 22:00:41 GMT</pubDate></item><item><title>French and Benelux stocks-Factors to watch on April 10</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12nipkfv3/*http://www.reuters.com/article/2013/04/10/france-benelux-stocks-idUSL5N0CX07420130410?feedType=RSS&amp;feedName=rbssHealthcareNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/439233440</guid><pubDate>Wed, 10 Apr 2013 05:45:37 GMT</pubDate></item><item><title>Ipsen signs research accord with Japan&apos;s Peptidream</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=126tfc8dp/*http://www.reuters.com/article/2013/04/10/ipsen-idUSWEB002NV20130410?feedType=RSS&amp;feedName=rbssHealthcareNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/2424437707</guid><pubDate>Wed, 10 Apr 2013 05:41:49 GMT</pubDate></item><item><title>PeptiDream and Ipsen Enter into a Collaboration for Advancing Drug Discovery Efforts for Peptides to Treat Serious Disease</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/peptidream-ipsen-enter-collaboration-advancing-053000981.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/3435926671</guid><pubDate>Wed, 10 Apr 2013 05:30:00 GMT</pubDate></item><item><title>Ipsen’s Dysport® approved for use in aesthetic medicine in Canada to be marketed by Medicis Aesthetics Canada</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ipsen-dysport-approved-aesthetic-medicine-053000094.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/3337556195</guid><pubDate>Tue, 09 Apr 2013 05:30:00 GMT</pubDate></item><item><title>The Ipsen Group Publishes Its 2012 Registration Document</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ipsen-group-publishes-2012-registration-170000732.html</link><description>[Business Wire] - Regulatory News :</description><guid isPermaLink="false">yahoo_finance/647342926</guid><pubDate>Wed, 27 Mar 2013 17:00:00 GMT</pubDate></item><item><title>Baxter closes deal for potential hemophilia drug</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/baxter-closes-deal-potential-hemophilia-133916692.html</link><description></description><guid isPermaLink="false">yahoo_finance/3162086642</guid><pubDate>Thu, 21 Mar 2013 13:39:16 GMT</pubDate></item><item><title>Ipsen and Inspiration Biopharmaceuticals announce closing of the sale of OBI-1 to Baxter International</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ipsen-inspiration-biopharmaceuticals-announce-closing-063000936.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/2318311645</guid><pubDate>Thu, 21 Mar 2013 06:30:00 GMT</pubDate></item><item><title>Q4 2012 IPSEN S A Earnings Release - 01:00 am ET</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20130227.html?t=ipn.pa</link><description></description><guid isPermaLink="false">yahoo_finance/705846051</guid><pubDate>Wed, 27 Feb 2013 12:07:06 GMT</pubDate></item><item><title>Ipsen posts 2012 loss on haemophilia market exit</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=12fdviito/*http://www.reuters.com/article/2013/02/27/ipsen-results-idUSL6N0BR1WL20130227?feedType=RSS&amp;feedName=rbssHealthcareNews&amp;rpc=43</link><description></description><guid isPermaLink="false">yahoo_finance/3915381296</guid><pubDate>Wed, 27 Feb 2013 07:30:04 GMT</pubDate></item><item><title>Christel Bories Joins Ipsen as Deputy Chief Executive Officer</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/christel-bories-joins-ipsen-deputy-060000337.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/1738926095</guid><pubDate>Wed, 27 Feb 2013 06:00:00 GMT</pubDate></item><item><title>Ipsen&apos;s 2012 Results and 2013 Financial Objectives</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ipsens-2012-results-2013-financial-060000725.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/3974584745</guid><pubDate>Wed, 27 Feb 2013 06:00:00 GMT</pubDate></item><item><title>Ipsen and Inspiration Biopharmaceuticals Announce Closing of the IB1001 Sale to Cangene Corporation</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ipsen-inspiration-biopharmaceuticals-announce-closing-063000992.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/1529784215</guid><pubDate>Wed, 20 Feb 2013 06:30:00 GMT</pubDate></item><item><title>Eziclen® / Izinova® a New Product for Bowel Cleansing Successfully Completed European Decentralised Registration Procedure</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/eziclen-izinova-product-bowel-cleansing-070000727.html</link><description>[Business Wire] - Regulatory News:</description><guid isPermaLink="false">yahoo_finance/437616756</guid><pubDate>Thu, 07 Feb 2013 07:00:00 GMT</pubDate></item></channel></rss>